title: Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse?
authors.affiliation: OncoEmatologia Pediatrica, Ospedale dei Bambini "G. Di Cristina", 90100 Palermo, Italy. arico@ospedalecivicopa.org
authors.forename: Maurizio
authors.initials: M
authors.lastname: Aricò
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Germano
authors.forename: Laura
authors.initials: L
authors.lastname: del Giudice
authors.forename: Ottavio
authors.initials: O
authors.lastname: Ziino
authors.forename: Franco
authors.initials: F
authors.lastname: Locatelli
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Basso
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001853:Bone Marrow / Q000473:pathology; D002675:Child, Preschool; D002999:Clone Cells / Q000473:pathology; D020732:Cytogenetic Analysis; D005260:Female; D006801:Humans; D018365:Neoplasm, Residual / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000188:drug therapy; D011379:Prognosis; D012008:Recurrence; D012074:Remission Induction / Q000379:methods